Marrone Bio Investors Say Ernst & Young Must Face Claims
A class of Marrone Bio Innovations Inc. shareholders on Monday urged a California federal court not to dismiss claims against Ernst & Young LLP over its alleged role in the bio-based...To view the full article, register now.
Already a subscriber? Click here to view full article